SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Jul 3, 2014
Insider Transaction Report
Form 4
REARDON WILLIAM S
Director
Transactions
- Award
Common Stock
2014-07-01+4,878→ 41,439 total - Award
Director Stock Option (Right to Buy)
2014-07-01+10,000→ 10,000 totalExercise: $4.10Exp: 2024-07-01→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015, provided the Reporting Person continues to serve as a director of the Issuer on such date.
- [F2]The option vests as to 25% of the shares on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015, provided the Reporting Person continues to serve as a director of the Issuer on such date.